Among the 8 genes, FHL2 and TGM2 already have been studied for ccRCC [29, 30], and, among the rest, GPX8 exhibited the highest cancer versus normal expression ratio with a high-enough expression level (Figs. 1B and S1B). This evidence concerns the gene FHL2 and cancer.